Cannabis Law Report

JULY 27, 2021

and its Scientific Advisory Board, the Organization Publishes New Real-World Study on Epilepsy and CBD. His first initiative is co-authoring an original study on epilepsy using survey data gathered from RoC’s innovative Observational Research Registry (ORR). Under the Leadership of Nicolas Schlienz, Ph.D., About Realm of Caring.

Data 105

Data Epilepsy Research and Development Clinical Trials 105

Canna Law Blog

OCTOBER 5, 2022

Different than us though, Japan allows for the sale of hemp-CBD products since products derived from the stalks and seeds of cannabis are not criminalized. Last year, it recommended that the government allow the use of marijuana to treat “refractory epilepsy.” Similar to how the U.S.

Marijuana 93

Marijuana Seed-To-Sale Clinical Trials Epilepsy 93

Otherside Farms

APRIL 26, 2021

What helps make CBD so effective in treating nerve-related issues? Can individuals rely on Plain Jane CBD products to protect their brain and central nervous system? Cannabidiol, better known as CBD, is a cannabinoid found in high quantities in hemp and marijuana. What Are the Neurological Effects of CBD?

Consumption 52

Consumption CBD Extraction Chronic Pain 52

Healer

DECEMBER 17, 2021

Studies have shown CBD to be a safe substance, but as with any new drug, you must make sure it doesn’t negatively interact with other medications. Numerous studies have shown that CBD is a safe, non-impairing, and non-habit-forming substance. Most often, CBD interacts with other drugs via liver metabolism. By Dr. Dustin Sulak.

CBD 52

CBD THC Conditions Medicine 52

Cannabis Law Report

DECEMBER 7, 2021

While cannabidiol was associated with a reduction in reported seizure events (RR?=?0.59, A qualitative assessment suggests that medical cannabinoids might be associated with adverse mental events. Adverse mental events were reported as well, however, more research should be performed to assess well this outcome. 1.69, 95% CI [1.20–2.36])

Safety 52

Safety Cannabinoids Events Data 52

Cannabis Law Report

JULY 26, 2021

About half to two-thirds of the cases get much better during adolescence[1]; however, adults will generally be more severe patients[2]. The patients will be randomized in 1:1 ratio to receive either SCI-110 or SCI-110 matched placebo. About SciSparc (OTCQB: SPRCY): SciSparc Ltd. Investor Contact: IR@scisparc.com. Tel: +972-3-6167055.

Research and Development 105

Research and Development Supply Chain Pharmaceutical Treatment 105

The Cannigma

MAY 19, 2021

Medical : Illegal Recreational : Illegal *CBD products are legal in Japan, as long as they contain no THC whatsoever and are not made from cannabis flower. Since 2016, the country has permitted the sale of CBD and some Japanese companies produce cannabidiol products as well. How much does CBD cost in Japan? Shutterstock).

Law 137

Law Legalization Clinical Trials CBD 137

The Joint Blog

JANUARY 10, 2022

CBD (cannabidiol) forms part of over 100 chemical components called cannabinoids discovered in the cannabis plant, Cannabis sativa. However, unlike THC, CBD lacks psychoactive effects. However, unlike THC, CBD lacks psychoactive effects. Over the years, consumer interest in CBD’s mental health benefits rose steadily.

CBD 41

CBD Sleep Treatment Epilepsy 41

CannaTech

APRIL 1, 2020

In practical terms, we studied how pharmaceuticals interact, how to accurately measure and dispense medications, advise patients on effective protocols and adverse events, what to do and not to do when using specific medications. Over 60,000 patients in Israel receive medical cannabis through pharmacies and distributors.

Supply Chain 98

Supply Chain Chronic Pain Pharmaceutical Patients 98

MMJ Recs

DECEMBER 20, 2023

The establishment of medical marijuana dispensaries in Virginia represents a progressive approach to healthcare, offering patients alternative treatment options for various medical conditions. Patients diagnosed with specific medical conditions are eligible to participate in the state’s medical cannabis program.

Dispensary 52

Dispensary Marijuana Strains Patients 52

Cannabis Life Network

AUGUST 15, 2019

News News See all Sundial Growers Reports Second Quarter Results August 15, 2019 Canopy Growth net revenues surge in first quarter on record cannabis harvest August 15, 2019 CBD strains for Anxiety and Depression August 15, 2019 Business. CBD strains have also been known to relieve anxiety and depression, but only for certain people.

Strains 80

Strains CBD Terpenes Cannabinoids 80

Cannabis Law Report

MAY 19, 2022

Food & Drug Administration (FDA) recently issued Warning Letters to five companies selling products containing delta-8 tetrahydrocannabinol (delta-8 THC) and cannabidiol (CBD). Like CBD, delta-8 THC is also derived from the Cannabis sativa plant. FDA states it has serious safety concerns with delta-8 THC.

THC 52

THC CBD Food Pets 52

WeedAdvisor

MARCH 29, 2019

In a pattern that is all-too-common for the cannabis industry, dispensaries are now plagued by a shortage on CBD oil, according to CBC News. While CBD was already well-known to many medical users, those with only recreational access quickly fell into the hype. Claims About CBD Drive Demand. .

Oil 40

Oil CBD Research and Development Epilepsy 40

SpeedWeed

APRIL 2, 2021

The legacy of Charlotte Figi, the young Colorado girl whose struggle with epilepsy made CBD known worldwide, will be remembered next week with a benefit concert taking place in her honor. She had a rare form of epilepsy known as Dravet syndrome that caused dozens or even hundreds of seizures per day. She was the catalyst.

Events 52

Events Epilepsy Cannabinoids Treatment 52

Cannabis Law Report

SEPTEMBER 24, 2019

T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. The medication, developed by GW Pharmaceuticals, will be used in combination with another epilepsy medication called clobazam. What about other medical cannabis products?

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Puff Puff Post

NOVEMBER 30, 2018

CBD Oil for Pets in Toronto: A New Frontier. CBD oil for pets in Toronto is fast becoming a growing trend. With human patients benefiting from CBD’s therapeutic effects, pet owners want to know if their furry family members can also benefit from the herb. They want to see if CBD oil can relieve their pet’s symptoms. .

Pets 76

Pets Oil CBD Research and Development 76

LifeCannMD

DECEMBER 13, 2021

This allowed patients with a debilitating medical condition to be able to buy and use Medical Marijuana. Medical Marijuana laws in Florida are designed with the patient’s health in mind. Additionally, cannabidiol (CBD) can help treat seizures, while also reducing anxiety. Learn more here. Learn more here. Learn more here.

Conditions 52

Conditions Chronic Pain Marijuana Patients 52

Cannabis Law Report

AUGUST 2, 2021

” A study conducted by The G4 Alliance reports 300 million surgical procedures are performed annually, with an estimated 60 to 70% of patients experiencing moderate to severe pain just after 24 hours of surgery. The global postoperative pain management market is expected to account for $45 billion by 2026. ” About The Study.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Green Relief

MAY 13, 2018

The benefits of CBD-rich cannabis concentrates for chronic traumatic encephalopathy (CTE) are well-known among football players and other pro athletes. government-held patent pertaining to “cannabinoids as antioxidants and neuroprotectants,” CBD and THC can limit “neurological damage following ischemic insults, such as stroke or trauma.”.

THC 64

THC CBD Cannabinoids Research and Development 64

CannaTech

FEBRUARY 3, 2020

CannaTech is an international event experience that unites cannabis professionals with breakout industry leaders for an unparalleled opportunity to learn, connect and define what’s next for the global cannabis industry. CBD-derived epilepsy drug Epidiolex is currently available in Swiss pharmacies as a prescription drug.

Events 52

Events Hemp CBD Medicine 52

SpeedWeed

MAY 5, 2021

Last week was eventful for cannabis reform in Texas, as the House of Representatives approved three legislative proposals, which would expand the state’s medical cannabis program, reduce penalties for concentrates and decriminalize possession. 1535 would also raise the THC limit in medical cannabis from 0.5%

Programs 52

Programs Chronic Pain Concentrates THC 52

SpeedWeed

MAY 4, 2021

Last week was eventful for cannabis reform in Texas, as the House of Representatives approved three legislative proposals, which would expand the state’s medical cannabis program, reduce penalties for concentrates and decriminalize possession. 1535 would also raise the THC limit in medical cannabis from 0.5%

Programs 52

Programs Chronic Pain Concentrates THC 52

Cannabis Law Report

AUGUST 24, 2021

Thus, there is a great need to develop new and effective therapeutics for treating patients. The Company’s second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction and epilepsy. In particular, IPF has an insidious, relentless and chronic course, with a median survival of two to five years.

Pharmaceutical 98

Pharmaceutical Clinical Trials Chronic Pain CBD 98

SMPL

MAY 26, 2020

They sat in a circle at a house in the hills a few hours north of San Francisco — where wine country becomes weed country — to discuss the therapeutic potential of CBD, and how to get people to take it seriously. Finally, there was Fred Gardner, a writer who had recruited almost all of these people to the CBD cause.

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

CannaMD

SEPTEMBER 15, 2020

Current Florida medical marijuana patient? Patients suffering from cancer, epilepsy, chronic seizures, or muscle spasms could use low-THC cannabis products recommended by a licensed doctor. Doctors and patients had to register on the Compassionate Use Registry , an online database maintained by the Florida Department of Health.

Law 126

Law Marijuana Patients Treatment 126

Puff Puff Post

MARCH 2, 2020

(Source: New Frontier Data). · Domestic quotas represent a further milestone in the Company’s stated timeline to bring the first medical cannabis products to market in Colombia, targeting patients with two priority conditions; chronic pain and nausea associated with chemotherapy. United States Disclaimer.

Extraction 52

Extraction THC Chronic Pain Cultivation 52

MMJ Recs

JUNE 25, 2021

The medical relief provided by these new laws helped many patients who had been suffering from long-term conditions. According to the Pennsylvania Department of Health, over half a million people in the state have a medical marijuana card for various health conditions such as cancer and epilepsy.

Conditions 52

Conditions Law Marijuana Events 52

The Cannigma

JANUARY 31, 2021

He said the organization also encourages members to take part in charity events (like 10k and 5k runs) that raise money and awareness for diseases that cannabis can potentially help treat, such as multiple sclerosis , cancer , and epilepsy. Cannabis simply reminds me to slow it down and stay patient.”.

THC 145

THC Cannabis Environment CBD 145

Otherside Farms

JANUARY 17, 2020

The Food and Drug Administration allows the use of CBD to treat pain, anxiety, depression, nausea, and some types of epilepsy. Is CBD able to offer the same effects? The trend of CBD infused foods is on the rise. We will look at the coordination between the CBD and people’s appetite and eating lifestyles.

Food 52

Food Research and Development Seed-To-Sale Vaping 52

Cannabis Law Report

DECEMBER 28, 2021

We added VRP324 which is an intranasally delivered cannabidiol (‘CBD’) formulation for the management of epilepsy in adults and children. Virpax anticipates enrollment of the first patient by early second quarter of 2022. to conduct this study in Canada. For more information, please visit www.virpaxpharma.com.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

Cannabis Law Report

NOVEMBER 18, 2021

Nadav Kidron, Oramed CEO and Oravax Chairman, and Rodrigo Herrera, Genomma Lab Chairman, will hold a joint press event today, Thursday, November 18, 2021 at 11:00 am EST. The live press event will be available via Zoom. The Company’s second drug platform, Supera-CBD , is being developed to treat chronic pain, addiction and epilepsy.

Pharmaceutical 52

Pharmaceutical Clinical Trials Business Chronic Pain 52

Puff Puff Post

MARCH 2, 2020

(Source: New Frontier Data). · Domestic quotas represent a further milestone in the Company’s stated timeline to bring the first medical cannabis products to market in Colombia, targeting patients with two priority conditions; chronic pain and nausea associated with chemotherapy. United States Disclaimer.

Extraction 40

Extraction THC Chronic Pain Cultivation 40

Cannabis Law Report

DECEMBER 20, 2021

First Patient Expected to be Enrolled by Q2 of 2022. The study will take place in Canada with a CTA filing and enrollment of the first patient anticipated by Q2 of 2022. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.

Clinical Trials 52

Clinical Trials Chronic Pain Pharmaceutical Data 52

Cannabis Law Report

MARCH 6, 2020

KLS-13019 has not been reviewed or approved for patient use by the U.S. was named a top CBD producer by CNBC. was also the first company to receive historic import permits for CBD products from the governments of Brazil , Mexico , Argentina , and Paraguay and is a leader in the development of international markets. .’s

Research and Development 59

Research and Development Marijuana Pharmaceutical Supply Chain 59

Veriheal

OCTOBER 5, 2020

These compounds mostly include cannabinoids such as tetrahydrocannabinol (THC) and cannabidiol (CBD) amongst many others such as cannabigerol (CBG). The program requires cannabis patients to have a licensed physician to certify that the individual would benefit from medical cannabis before they can register for it.

Edibles 52

Edibles Legalization Decriminalization Consumption 52

MassRoots

NOVEMBER 19, 2018

Whereas Grassley has refused to let any marijuana bills come to a vote as Judiciary chairman, Graham has made surprise appearances as a cosponsor of legislation to protect legal medical states from federal interference, reschedule cannabis and also remove cannabidiol (CBD) from the list of federally banned substances.

Marijuana 56

Marijuana Policy Legislation Research and Development 56

Cannabis Law Report

DECEMBER 29, 2021

The company has received clearance from the South African Health Products Regulatory Authority to begin patient enrollment in a first-in-human clinical trial and preparations to begin that trial are underway. The Company’s second drug platform, Supera-CBD , is being developed to treat chronic pain, addiction and epilepsy.

Pharmaceutical 52

Pharmaceutical Clinical Trials Chronic Pain CBD 52